InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: Tartiaboy post# 2490

Monday, 01/28/2019 10:40:25 AM

Monday, January 28, 2019 10:40:25 AM

Post# of 3283
Decaf just shared this list of mBC candidates: DS-8201, Tucatinib, Pyrotinib, possibly Neratinib. It is what I am aware of. I am sure, there are some others.

SPPI just terminated the Pozi + T-DM1 phase I combination trial. Decaf thinks SPPI may be abandoning mBC.